Casa
o que significa a fórmula y=c+i+g+(x-m)

The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3

Por um escritor misterioso

Descrição
IMR Press is a leading publisher of open access peer-reviewed biomedical and life sciences journals. We aim to facilitate the dissemination of high-quality research in the area of biomedical science. With a long tradition and wide readership, IMR Press is dedicated to making positive contributions to academics, corporate libraries as well as to readers and authors. All the editors in IMR Press will provide the best service for researchers, allowing them to have a easy and smooth publication experience and helping maximize the impact and visibility of their research.
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Figure 5 from Cardiorenal Syndrome Revisited
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Cardiorenal Syndrome Journal of the American College of Cardiology
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Renal fibrosis in type 2 cardiorenal syndrome: An update on
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Cardiovascular Consequences of Acute Kidney Injury
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Cardiorenal syndrome: Multi‐organ dysfunction involving the heart
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Cells, Free Full-Text
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Cardiac Spinal Afferent Denervation Attenuates Renal Dysfunction
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Acute cardiorenal syndrome: Mechanisms and clinical implications
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Progress and Challenges of Understanding Cardiorenal Syndrome Type 3
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
PDF] Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Mechanism of damage in CRS-3. CRS, cardiorenal syndrome; GFR
de por adulto (o preço varia de acordo com o tamanho do grupo)